Abstract:Abstract Background Pancreatic cancer continues to have an extremely poor prognosis in part due to late diagnosis. 25% of pancreatic cancer patients have a prior diagnosis of diabetes, and hence identifying individuals at risk of pancreatic cancer in those with recently diagnosed type 2 diabetes may be a useful opportunity to identify candidates for screening and early detection. In this study, we will comparatively evaluate regression and machine learning-based clinical prediction models for estimating individual risk of developing pancreatic cancer two years after type 2 diabetes diagnosis. Methods In the development dataset, we will include adults aged 30-84 years with incident type-2 diabetes registered with QResearch primary care database. Patients will be followed up from type-2 diabetes diagnosis to first diagnosis of pancreatic cancer as recorded in any one of primary care records, hospital episode statistics, cancer registry data, or death records. Cox-proportional hazards models will be used to develop a risk prediction model for estimating individual risk of developing pancreatic cancer during up to 2 years of follow-up. We will perform variable selection using a combination of clinical and statistical significance approach i.e. HR 1.1 and p<0.01. Linear predictors and baseline survivor function at 2 years will be used to compute absolute risk predictions. Internal-external cross-validation (IECV) framework across geographical regions within England will be used to assess performance and pooled using random effects meta-analysis using: (i) model fit in terms of variation explained by the model Royston & Sauerbrei’s R2D, (ii) calibration slope and calibration-in-the-large, and (iii) discrimination measured in terms of Harrell’s C and Royston & Sauerbrei’s D-statistic. Further, we will evaluate machine learning (ML) approaches for the clinical prediction model using neural networks (NN) and XGBoost. The model predictors and performance of these will be compared with the results of those derived from the regression-based strategy. Discussion The proposed study will develop and validate a novel risk prediction model to aid early diagnosis of pancreatic cancer in patients with new-onset diabetes in primary care. With an enhanced decision-risk tool for use at point-of care by general practitioners to assess pancreatic cancer risk, it may improve decision-making so that at-risk patients are rapidly prioritised to aid early diagnosis of pancreatic cancer in patients with newly diagnosed diabetes.

S180 Prediction of New-Onset Diabetes Following Acute and Chronic Pancreatitis Using Machine Learning Algorithms: Analysis of Large Real-World Data

Prediction of the Severity of Acute Pancreatitis Using Machine Learning Models.

Machine learning for post-acute pancreatitis diabetes mellitus prediction and personalized treatment recommendations

Predicting Pancreatic Cancer in New‐Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indicators: A Large‐Scale Prospective Cohort Study

Early Prediction of Severe Acute Pancreatitis Using Machine Learning

Prediction of Diabetes using Machine Learning

Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters

Prediction of Diabetes Progress Based on Machine Learning Approach

Prediction of diabetic kidney disease with machine learning algorithms, upon the initial diagnosis of type 2 diabetes mellitus

A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning

Machine Learning Predictive Models for Acute Pancreatitis: A Systematic Review.

Predicting the onset of diabetes-related complications after a diabetes diagnosis with machine learning algorithms

Predicting the Need for Therapeutic Intervention and Mortality in Acute Pancreatitis: A Two-Center International Study Using Machine Learning

Machine Learning Improves Prediction of Severity and Outcomes of Acute Pancreatitis: a Prospective Multi-Center Cohort Study

Diabetes Prediction using Artificial Intelligence and Machine Learning

A Machine Learning Approach for Prediction of Diabetes Mellitus

PREDICTIVE MODELLING FOR DIABETES USING MACHINE LEARNING

Machine Learning-Based Predictive Modeling of Diabetic Nephropathy in Type 2 Diabetes Using Integrated Biomarkers: A Single-Center Retrospective Study

Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the development and validation of a clinical prediction model (QPancreasD)

Prediction of Incident Diabetic Retinopathy in Adults With Type 1 Diabetes Using Machine Learning Approach: An Exploratory Study

Diabetes mellitus prediction using machine learning within the scope of a generic framework